Results 201 to 210 of about 952 (211)

Dipeptidyl peptidase-4 inhibitors/metformin

Reactions Weekly, 2018
openaire   +1 more source

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Current Medical Research and Opinion, 2009
Richard Pratley
exaly  

Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes

Expert Opinion on Pharmacotherapy, 2016
exaly  

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon–Like Peptide 1–Dependent Mechanism

Hypertension, 2012
Yi-Xiang Wang, Aimin Xu, Xiaoqiang Yao   +2 more
exaly  

Sitagliptin: A Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Annals of Pharmacotherapy, 2006
exaly  

Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180

Frontiers in Immunology, 2019
Yosuke Mai, Kentaro Izumi, Wataru Nishie   +2 more
exaly  

Synthesis of a Dipeptidyl Peptidase-4 Inhibitor

Synfacts, 2014
openaire   +1 more source

Genetically Targeted Dipeptidyl Peptidase-4 Inhibitor Use in a Patient with a Novel Mutation of MODY type 4

Clinical Medicine Insights: Endocrinology and Diabetes, 2015
Vijay Shivaswamy, Eric Rush
exaly  

Dipeptidyl peptidase-4 (DPP-4) inhibitors

British Journal of Cardiology, 2017
openaire   +1 more source

Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes

Expert Opinion on Pharmacotherapy, 2012
exaly